Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00031915
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
National Cancer Institute (NCI)
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT04211675
What this trial is testing

NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Who this might be right for
Relapsed NeuroblastomaRefractory Neuroblastoma
Nationwide Children's Hospital 31
Not applicableEnded earlyNCT02693171
What this trial is testing

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

Who this might be right for
Neuroblastoma
United Therapeutics 13
Early research (Phase 1)Active Not RecruitingNCT04337177
What this trial is testing

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Who this might be right for
Solid TumorsNeuroblastomaRhabdomyosarcoma+3 more
Valent Technologies, LLC 20
Not applicableLooking for participantsNCT05199376
What this trial is testing

Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

Who this might be right for
NeurofibromaNeurofibroma, Plexiform
Centre Leon Berard 30
Early research (Phase 1)Study completedNCT00003191
What this trial is testing

Fenretinide in Treating Children With Solid Tumors

Who this might be right for
NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 18
Early research (Phase 1)UnknownNCT05782959
What this trial is testing

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Who this might be right for
Neuroblastoma
Biocad 24
Testing effectiveness (Phase 2)Study completedNCT00464620
What this trial is testing

Trial of Dasatinib in Advanced Sarcomas

Who this might be right for
RhabdomyosarcomaMalignant Peripheral Nerve Sheath TumorsChondrosarcoma+7 more
Sarcoma Alliance for Research through Collaboration 366
Testing effectiveness (Phase 2)Looking for participantsNCT04559217
What this trial is testing

68Ga-DOTATATE Neuroblastoma Imaging Pilot

Who this might be right for
Neuroblastoma
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 20
Early research (Phase 1)Temporarily pausedNCT01083966
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Who this might be right for
Vestibular Schwannoma
Northwell Health 30
Not applicableStudy completedNCT07712302
What this trial is testing

Effect of GMI With and Without NM on LE in Cancer Patients With CIPN

Who this might be right for
Chemotherapy Induced Peripheral Neuropathy (CIPN)Cancer
University of Faisalabad 48
Early research (Phase 1)Study completedNCT02909777
What this trial is testing

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Who this might be right for
LymphomaNeuroblastomaBrain Tumor+1 more
Dana-Farber Cancer Institute 26
Early research (Phase 1)Study completedNCT01172028
What this trial is testing

Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+4 more
University of Arizona 33
Not applicableUnknownNCT02078401
What this trial is testing

Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

Who this might be right for
Neurofibromatosis Type 1
Universitaire Ziekenhuizen KU Leuven 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Not applicableUnknownNCT02505412
What this trial is testing

Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients

Who this might be right for
Neurofibromatosis Type 1
Tel-Aviv Sourasky Medical Center 50
Not applicableStudy completedNCT00276640
What this trial is testing

Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas

Who this might be right for
Primary Central Nervous System Neoplasms
Societe Internationale d'Oncologie Pediatrique 3,417
Next Page